14.	Acquisitions

During the first three months of 2015, the Company acquired dialysis businesses and other businesses consisting of one dialysis center located in the U.S., two vascular access centers, and other medical businesses for a total of $40,650 in net cash and deferred purchase price obligations totaling $394. The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company’s condensed consolidated financial statements and operating results from the designated effective dates of the acquisitions. Certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of medical claims reserves and certain other working capital items relating to several of these acquisitions are pending final quantification.

The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values:

	Three months ended
	March 31, 2015
Current assets	$	1,203
Property and equipment		8,880
Amortizable intangible and other long-term assets		3,614
Goodwill		31,607
Noncontrolling interests assumed		(2,494	)
Liabilities assumed		(1,766	)
Aggregate purchase price	$	41,044

Amortizable intangible assets acquired during the first three months of 2015 had weighted-average estimated useful lives of five years. The majority of the intangible assets acquired relate to non-compete agreements, assembled work forces, and trade names. The weighted-average amortization period for non-compete agreements was six years. The weighted-average amortization period for assembled work forces was five years. The weighted-average amortization period for trade names was three years. The total amount of goodwill deductible for tax purposes associated with these acquisitions was approximately $29,111.

Contingent earn-out obligations

The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former shareholders of those acquired companies a total of up to approximately $134,321 or a portion of that amount if certain EBITDA performance targets and quality margins are met over the next two years, if certain percentages of operating income are met over the next three years or if certain percentages of other annual EBITDA targets are met. As of March 31, 2015, the Company has estimated the fair value of these contingent earn-out obligations to be $38,425.

Contingent earn-out obligations will be remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the re-measurement recorded in earnings. See Note 16 to the condensed consolidated financial statements for further details. Of the total contingent earn-out obligations of $38,425 recognized at March 31, 2015, a total of $15,885 is included in other liabilities and the remaining $22,540 is included in other long-term liabilities in the Company’s condensed consolidated balance sheet.

The following is a reconciliation of changes in the contingent earn-out obligations for the three months ended March 31, 2015:

Beginning balance, January 1, 2015	$	39,129
Remeasurement of fair value for other contingent earn-outs		(704	)
	$	38,425